Dr Matthew KrebsMB ChB MRCP PhD

Clinical Snr Lecturer in Exp Cancer Med

View graph of relations

Publications

  1. 2019
  2. Published

    EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

    Lindsay, C. R., Blackhall, F. H., Carmel, A., Fernandez-Gutierrez, F., Gazzaniga, P., Groen, H. J. M., Hiltermann, T. J. N., Krebs, M. G., Loges, S., López-López, R., Muinelo-Romay, L., Pantel, K., Priest, L., Riethdorf, S., Rossi, E., Terstappen, L., Wikman, H., Soria, J. C., Farace, F., Renehan, A. & 3 othersDive, C., Besse, B. & Michiels, S., 1 Aug 2019, In : European Journal of Cancer. 117, p. 60-68 9 p.

    Research output: Contribution to journalArticle

  3. Published

    Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial

    Herbst, R. S., Arkenau, H. T., Santana-Davila, R., Calvo, E., Paz-Ares, L., Cassier, P. A., Bendell, J., Penel, N., Krebs, M. G., Martin-Liberal, J., Isambert, N., Soriano, A., Wermke, M., Cultrera, J., Gao, L., Widau, R. C., Mi, G., Jin, J., Ferry, D., Fuchs, C. S. & 2 othersPetrylak, D. P. & Chau, I., 1 Aug 2019, In : The Lancet Oncology. 20, 8, p. 1109-1123 15 p.

    Research output: Contribution to journalArticle

  4. Accepted/In press

    EPAC-Lung: Pooled Analysis of Circulating Tumor Cells in Advanced Non-Small Cell Lung Cancer

    Lindsay, C., Blackhall, F., Carmel, A., Fernandez-Gutierrez, F., Gazzaniga, P., Groen, H. J. M., Hiltermann, T. J. N., Krebs, M., Loges, S., López-López, R., Muinelo-Romay, L., Pantel, K., Priest, L., Rietdorf, S., Rossi, E., Terstappen, L., Wikman, H., Soria, J-C., Farace, F., Renehan, A. & 3 othersDive, C., Besse, B. & Michiels, S., 9 May 2019, (Accepted/In press) In : European Journal of Cancer.

    Research output: Contribution to journalArticle

  5. Published

    Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer

    Tinsley, N., Zhou, C., Tan, G., Rack, S., Lorigan, P., Blackhall, F., Krebs, M., Carter, L., Thistlethwaite, F., Graham, D. & Cook, N., 2019, In : The oncologist.

    Research output: Contribution to journalArticle

  6. Published

    Neoantigen-directed immune escape in lung cancer evolution

    The TRACERx consortium, 2019, In : Nature. 567, 7749, p. 479-485 7 p.

    Research output: Contribution to journalArticle

  7. Published

    Utility of ctDNA to support patient selection for early phase clinical trials: The TARGET Study

    Rothwell, D., Ayub, M., Cook, N., Thistlethwaite, F., Carter, L., Dean, E., Smith, N., Villa, S., Dransfield, J., Dive, C., Clipson, A., White, D., Nessa, K., Ferdous, S., Howell, M., Gupta, A., Kilerci, B., Mohan, S., Frese, K., Gulati, S. & 23 othersMiller, C., Jordan, A., Eaton, H., Hickson, N., C, OB., Graham, D., Kelly, C., Aruketty, S., Metcalf, R., Chiramel, J., Tinsley, N., AJ, V., Kurup, R., Forest, H., Stevenson, J-A., Southam, S., Landers, D., Wallace, A., Marais, R., Hughes, A., Brady, G., Dive, C. & Krebs, M., 2019, In : Nature Medicine. 25, 5, p. 738-743 6 p.

    Research output: Contribution to journalArticle

  8. 2018
  9. Published

    Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin

    Torres-ayuso, P., Sahoo, S., Ashton, G., An, E., Simms, N., Galvin, M., Leong, H. S., Frese, K. K., Simpson, K., Cook, N., Hughes, A., Miller, C. J., Marais, R., Dive, C., Krebs, M. G. & Brognard, J., 1 Dec 2018, In : Genomic Medicine. 3, 1

    Research output: Contribution to journalArticle

  10. Published

    Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open-Label, Phase I Trial (JVDF)

    Arkenau, H-T., Martin-Liberal, J., Calvo, E., Penel, N., Krebs, M. G., Herbst, R. S., Walgren, R. A., Widau, R. C., Mi, G., Jin, J., Ferry, D. & Chau, I., Dec 2018, In : The oncologist. 23, 12, p. 1407-e136

    Research output: Contribution to journalArticle

  11. Published

    Antibiotic use and efficacy of small molecule inhibitors in patients with advanced cancer

    Tan, G., Tinsley, N., Zhou, C., Villa, S., Lorigan, P., Blackhall, F., Krebs, M., Carter, L., Thistlethwaite, F., Hughes, A. & Cook, N., 8 Nov 2018, In : British Journal of Cancer. 119, 11, p. 25-25

    Research output: Contribution to journalMeeting Abstract

  12. Published

    Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer

    Basu, B., Krebs, M. G., Sundar, R., Wilson, R. H., Spicer, J., Jones, R., Brada, M., Talbot, D. C., Steele, N., Ingles Garces, A. H., Brugger, W., Harrington, E. A., Evans, J., Hall, E., Tovey, H., De Oliveira, F. M., Carreira, S., Swales, K., Ruddle, R., Raynaud, F. I. & 8 othersPurchase, B., Dawes, J. C., Parmar, M., Turner, A. J., Tunariu, N., Banerjee, S., De Bono, J. S. & Banerji, U., 17 Jul 2018, In : Annals of Oncology. 29, 9, p. 1918-1925

    Research output: Contribution to journalArticle

Previous 1 2 3 4 Next

Research Explorer downloads

13